Unlock stock picks and a broker-level newsfeed that powers Wall Street.
OTC Markets OTCPK - Delayed Quote USD

Genus plc (GENSF)

Compare
25.10
0.00
(0.00%)
At close: April 2 at 4:00:00 PM EDT
Loading Chart for GENSF
  • Previous Close 0.00
  • Open 25.10
  • Bid 23.24 x 40000
  • Ask 25.11 x 40000
  • Day's Range 25.10 - 25.10
  • 52 Week Range 20.51 - 28.01
  • Volume 300
  • Avg. Volume 81
  • Market Cap (intraday) 1.649B
  • Beta (5Y Monthly) 0.60
  • PE Ratio (TTM) --
  • EPS (TTM) -0.08
  • Earnings Date Feb 27, 2025
  • Forward Dividend & Yield 0.41 (1.63%)
  • Ex-Dividend Date Mar 6, 2025
  • 1y Target Est --

Genus plc operates as an animal genetics company in North America, Latin America, the United Kingdom, rest of Europe, the Middle East, Russia, Africa, and Asia. The company operates through three segments: Genus PIC, Genus ABS, and Genus Research and Development. It sells breeding pigs and semen to breed pigs with various characteristics for pork production under the PIC brand. The company also sells bull semen and embryos to breed calves with various characteristics for milk and beef production under the ABS, Genus, and Bovec brands. Further, it offers technical services to farmers. The company was incorporated in 1994 and is based in Basingstoke, the United Kingdom.

www.genusplc.com

3,500

Full Time Employees

June 30

Fiscal Year Ends

Recent News: GENSF

View More

Performance Overview: GENSF

Trailing total returns as of 4/3/2025, which may include dividends or other distributions. Benchmark is FTSE 100 (^FTSE) .

YTD Return

GENSF
20.04%
FTSE 100 (^FTSE)
4.17%

1-Year Return

GENSF
9.16%
FTSE 100 (^FTSE)
7.27%

3-Year Return

GENSF
32.50%
FTSE 100 (^FTSE)
12.95%

5-Year Return

GENSF
15.38%
FTSE 100 (^FTSE)
57.22%

Compare To: GENSF

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: GENSF

View More

Valuation Measures

Annual
As of 4/2/2025
  • Market Cap

    1.58B

  • Enterprise Value

    1.90B

  • Trailing P/E

    --

  • Forward P/E

    23.87

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    1.92

  • Price/Book (mrq)

    2.47

  • Enterprise Value/Revenue

    2.19

  • Enterprise Value/EBITDA

    24.15

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -0.60%

  • Return on Assets (ttm)

    3.81%

  • Return on Equity (ttm)

    -1.17%

  • Revenue (ttm)

    671.6M

  • Net Income Avi to Common (ttm)

    -4M

  • Diluted EPS (ttm)

    -0.08

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    47.4M

  • Total Debt/Equity (mrq)

    57.63%

  • Levered Free Cash Flow (ttm)

    89.54M

Research Analysis: GENSF

View More

Company Insights: GENSF

Research Reports: GENSF

View More

People Also Watch